SCHEMBL25461571

SCHEMBL25461571

c1ccc2c(-c3nccc4c3oc3ccccc34)ncnc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
LIMK1 P53667 1/20 0.41
LMNA P02545 4/20 0.41
NPC1 O15118 3/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
NCOA1 Q15788 2/20 0.40
MAPT P10636 4/20 0.39
TSHR P16473 2/20 0.39
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 6/20 0.38
HPGD P15428 4/20 0.38
PI4KA P42356 1/20 0.38
PI4K2B Q8TCG2 1/20 0.38
PI4K2A Q9BTU6 1/20 0.38
PI4KB Q9UBF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25461572 0.88 NCOA1 (0.45) SMN1; SMN2LIMK1LMNANPC1KMT2A
SCHEMBL25461636 0.82 ADORA2A (0.49) ADORA2ASMN1; SMN2LIMK1NPC1KMT2A
SCHEMBL24596447 0.81 ADK (0.47) ADORA2ASMN1; SMN2LIMK1LMNANPC1
SCHEMBL25461188 0.80 NPC1 (0.46) SMN1; SMN2LIMK1LMNANPC1KMT2A
SCHEMBL25462835 0.80 ADORA2A (0.37) ADORA2ALMNAKMT2AMEN1USP2
SCHEMBL25462840 0.80 PIK3CA (0.46) ADORA2ASMN1; SMN2LMNANPC1KMT2A
SCHEMBL25461682 0.79 TOP2A (0.44) SMN1; SMN2LIMK1LMNANPC1KMT2A
SCHEMBL11941239 0.78 ALDH1A1 (0.41) SMN1; SMN2LIMK1LMNANPC1KMT2A
SCHEMBL24796192 0.76 MAPT (0.51) SMN1; SMN2LIMK1LMNANPC1KMT2A
SCHEMBL22410587 0.76 SMN1; SMN2 (0.44) SMN1; SMN2LIMK1LMNANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 ADORA2A 3563/4885SMN1; SMN2 1824/4885LIMK1 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.